OxySure (OXYS) Adds Territory Sales Manager in the Dallas-Fort Worth Area
Frisco, Texas, April 28, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced the addition of a new Territory Sales Manager in the Dallas-Fort Worth area. This appointment follows the most recent announcements by the Company of several key Territory Manager appointments, including positions in Phoenix, Atlanta, Pittsburgh, Denver and Michigan.
“We are continuing to execute on our sales plans for 2015 and beyond by building a strong sales and distribution footprint nationally,” stated Julian T. Ross, CEO of OxySure. “We expect to announce additional staffing and corporate updates in the near future,” Ross added.
Specific details regarding the most recent sales appointment are as follows:
* Tacey Ferraro – Territory Manager, Dallas/Fort Worth: Ms. Ferraro is joining OxySure following several successful sales positions with companies such as MultiView, CFO Advisory Services, Lane Gorman Trubitt and Stratmark. Ms. Ferraro held numerous roles within these organizations from National Account Executive to Business Development Officer. Her distinguished sales career began with Pitney Bowes in the Corporate Sales Training Division in Peachtree City, GA. Ms. Ferraro has consistently over achieved on her quotas while establishing strong high level relationships within the business to business sector. She holds a Bachelor of Science, Sales and Marketing degree from the University of Nevada. Ms. Ferraro also did post graduate studies at L’Alliance Francaise in Paris, France.
At OxySure Ms. Ferraro will focus on developing new resuscitation business within the corporate, government, public access and school markets, while also supporting and expanding our existing distribution partnerships and current strategic alliances in the DFW area.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Forward-Looking Statements
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.
Investor Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
Richard Dupuy: rdupuy@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Redchip Companies, Inc.
Jon Cunningham: jon@redchip.com
800-733-2447, ext. 107
Tags: